Simplified prothrombin time standardization

Area of Science:

• Clinical Chemistry
• Hematology
• Biomedical Engineering

Background:

• Prothrombin time (PT) is a critical measure of the extrinsic pathway of coagulation.
• Current PT standardization methods, including the ratio method, present challenges with complex calibration and broad therapeutic ranges.
• Variability in assay sensitivity to Vitamin K antagonist drugs (e.g., warfarin) complicates standardization using coagulation activities.

Purpose of the Study:

• To analyze existing prothrombin time (PT) standardization methods.
• To introduce and evaluate a novel modified coagulation activity method for PT standardization.
• To address the limitations of current methods regarding calibration complexity and therapeutic range variability.

Main Methods:

• Analysis of the recommended ratio method for PT standardization.
• Evaluation of standardization by coagulation activities, considering assay sensitivity to Vitamin K absence (Pivka) inhibitors.
• Development and application of a modified coagulation activity method using a reference assay for calibration via clotting times.

Main Results:

• The current ratio method exhibits complex calibration and wide therapeutic ranges.
• Standardization by coagulation activities yields varying therapeutic ranges due to differential assay sensitivity to Pivka inhibitors.
• The modified coagulation activity method demonstrated simple calibration, narrow therapeutic ranges, and consistent results across different PT assays.

Conclusions:

• The modified coagulation activity method is a preferable approach for PT standardization.
• This novel method simplifies calibration and reduces therapeutic range variability.
• The modified coagulation activity method ensures identical PT assay results, improving clinical reliability.